SCN4B and cancer: The overexpression of SCN4B gene, confirmed by qPCR and western blotting experiments (Supplementary Fig. 8a,b), significantly reduced cancer cell invasiveness by 51.6±6.8% (n=6) in oeSCN4B as compared with control cells and by about 82% as compared with shSCN4B cells (Fig. 8a).